Qui tam is a legal mechanism that allows private citizens to file lawsuits on behalf of the federal government against individuals or organizations committing fraud, particularly against government-funded programs like Medicare and Medicaid. In healthcare, these cases are the primary tool for exposing billing fraud, illegal kickbacks, and other schemes that cost taxpayers billions of dollars each year. The term comes from a Latin phrase meaning “he who sues on behalf of the king as well as for himself,” reflecting the dual nature of the action: the whistleblower helps the government recover stolen funds and receives a financial reward for doing so.
How Qui Tam Works Under the False Claims Act
Qui tam lawsuits are authorized by the False Claims Act, a federal statute originally enacted in 1863 to combat defense contractor fraud during the Civil War. The law has since become the government’s most powerful weapon against healthcare fraud. It allows any person with knowledge of fraud against a federal program to bring a civil lawsuit, even if they weren’t personally harmed. The person filing the suit is called a “relator,” though they’re more commonly known as a whistleblower.
The financial scale of these cases is enormous. In fiscal year 2024, False Claims Act settlements and judgments exceeded $2.9 billion. More than $1.67 billion of that total came from the healthcare industry alone, involving managed care providers, hospitals, pharmacies, pharmaceutical companies, laboratories, and physicians.
The Filing Process
Filing a qui tam case follows a specific and unusual procedure. The whistleblower must file the civil complaint under seal with the court, meaning it’s kept confidential and the defendant is not served or even notified at this stage. At the same time, the whistleblower must provide a copy of the complaint along with a written disclosure of substantially all material evidence and information they possess to both the Attorney General and the local United States Attorney.
The government then has 60 days from the date it receives both the complaint and the evidence to decide whether to intervene, meaning it takes over the case and leads the litigation itself. In practice, the government frequently requests extensions, and this sealed period can stretch for months or even years while investigators build the case. If the government decides to intervene, it takes the lead in prosecuting the fraud. If it declines, the whistleblower can still pursue the lawsuit independently.
Government intervention matters enormously. Cases where the Department of Justice steps in tend to settle for larger amounts and succeed at much higher rates, partly because the government brings significant investigative resources and legal weight to the table.
Common Healthcare Fraud That Triggers Qui Tam Cases
Healthcare qui tam cases typically revolve around a few recurring types of fraud. The most common involve billing schemes, illegal financial relationships between providers, and kickbacks tied to patient referrals.
- Upcoding and unbundling: Providers bill Medicare or Medicaid for more expensive services than they actually delivered, or they break apart procedures that should be billed together to inflate the total reimbursement.
- Kickbacks: Pharmaceutical manufacturers, physicians, pharmacists, or other healthcare professionals offer or receive something of value in exchange for patient referrals or for ordering goods and services reimbursed by federal programs. Even when the billed services were actually provided, courts consider those claims “tainted by fraud” if kickbacks influenced the transaction.
- Physician self-referral violations: The Stark Law prohibits physicians from referring patients to entities in which they have a financial interest. Claims resulting from these prohibited referrals can be considered false under the False Claims Act.
- Fraudulent practice acquisitions: When healthcare providers overpay to acquire medical practices as a way to secure future referrals, then bill Medicare for those referred patients, the resulting claims can trigger False Claims Act liability.
A critical legal concept tying these violations together is “implied false certification.” Every time a provider submits a claim for Medicare or Medicaid reimbursement, they are implicitly certifying that they’ve complied with all relevant laws and regulations. If a kickback or self-referral violation exists, that certification is considered false, and the claim becomes fraudulent under the False Claims Act. Importantly, the whistleblower does not need to prove that the government suffered actual financial damages to bring a valid claim.
Who Files These Lawsuits
Most healthcare qui tam cases are filed by insiders: employees, former employees, or business associates who witnessed the fraud firsthand. Nurses, billing specialists, compliance officers, pharmacists, and physicians are among the most common whistleblowers. They typically have access to internal records, billing data, or communications that form the backbone of the evidence.
The whistleblower’s knowledge matters because the False Claims Act requires the complaint to be based on direct, original information rather than publicly available reports. Someone who simply reads about a company’s suspicious billing in the news generally cannot file a successful qui tam case. The law rewards people who bring genuinely new evidence of fraud to the government’s attention.
Financial Rewards for Whistleblowers
Qui tam whistleblowers are entitled to a percentage of whatever the government recovers. When the government intervenes and leads the case, the whistleblower typically receives between 15% and 25% of the recovery. When the government declines to intervene and the whistleblower pursues the case alone, that share increases to between 25% and 30%. Given that healthcare settlements frequently reach tens or hundreds of millions of dollars, these percentages can translate into life-changing sums.
The financial incentive is deliberate. Congress designed the reward structure to motivate insiders to come forward despite the personal and professional risks involved in exposing fraud at their workplace.
Protections Against Retaliation
The False Claims Act includes an anti-retaliation provision under Section 3730(h) that specifically protects whistleblowers from being punished for their role in exposing fraud. If an employer fires, demotes, suspends, threatens, harasses, or discriminates against an employee for filing a qui tam action or assisting in an investigation, the employee can seek remedies including reinstatement, back pay, and compensation for any costs or damages caused by the retaliation.
These protections apply not only to people who file formal lawsuits but also to employees who take preliminary steps toward reporting fraud, such as gathering evidence or raising concerns internally. The threshold for protection is relatively broad: you don’t have to file a lawsuit to be covered, but your actions need to be connected to a reasonable belief that fraud is occurring.
Why Qui Tam Matters in Healthcare
Medicare and Medicaid spend over a trillion dollars annually, making them the largest targets for fraud in the federal budget. The government simply cannot monitor every claim, every provider relationship, and every billing practice across the entire healthcare system. Qui tam fills that gap by turning the people closest to the fraud into the government’s eyes and ears. More than half of all False Claims Act recoveries originate from whistleblower-filed cases rather than government-initiated investigations, making qui tam the single most effective fraud detection tool in healthcare.
For healthcare workers who suspect their employer is defrauding Medicare or Medicaid, understanding qui tam means understanding that the law was specifically designed to make it possible for them to act on what they know, with both financial incentives and legal protections built into the process.